Comment to “Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO ‘MDS-U’ designation” Haematologica. 2012;97(12):1845-9.
Andreas Holbro,
Martine Jotterand,
Jakob R Passweg,
Andreas Buser,
André Tichelli,
Alicia Rovó
Affiliations
Andreas Holbro
Division of Hematology, University Hospital Basel;Blood Transfusion Centre, Swiss Red Cross, Basel
Martine Jotterand
Service de Génétique Médicale, University of Lausanne, Switzerland
Jakob R Passweg
Division of Hematology, University Hospital Basel
Andreas Buser
Division of Hematology, University Hospital Basel;Blood Transfusion Centre, Swiss Red Cross, Basel